GE HealthCare (GEHC) is working with Diagnoly, a company specializing in AI-driven prenatal screening, to advance the use of AI in fetal ultrasound assessments.
Through this agreement, the two companies will integrate Diagnoly’s Fetoly software within GEHC's Voluson women’s health ultrasound systems. This aims to help clinicians streamline exams, reduce workload, and improve consistency and accuracy of fetal assessments.
Fetoly is aligned with International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) guidelines, Diagnoly said. It provides clinical diagnostic support for fetal heart and brain analysis while continuously verifying exam completeness and quality criteria in real-time.
Fetoly has 510(k) clearance from the U.S. Food and Drug Administration 510(k) and is CE marked. The AI application is available as a free trial on the Voluson Solution Store and other major mobile app platforms.
